C3 glomerulopathy: Clinicopathologic features and predictors of outcome

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 1, 2014, Pages 46-53

  Medjeral Thomas, Nicholas R ^a,b   O'Shaughnessy, Michelle M ^c   O'Regan, John A ^c   Traynor, Carol ^c   Flanagan, Michael ^c   Wong, Limy ^c   Teoh, Chia Wei ^d   Awan, Atif ^d   Waldron, Mary ^e   Cairns, Tom ^a   O'Kelly, Patrick ^c   Dorman, Anthony M ^c   Pickering, Matthew C ^b   Conlon, Peter J ^c   Cook, H Terence ^a,b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BEAUMONT HOSPITAL   (Ireland)

^d CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^e OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTREPTOLYSIN; COMPLEMENT COMPONENT C3; CREATININE; SERUM ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DYSPROTEINEMIA; ELECTRON MICROSCOPY; FEMALE; GLOMERULOPATHY; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MILD RENAL IMPAIRMENT; MORBIDITY; OUTCOME VARIABLE; PREDICTOR VARIABLE; PROTEINURIA;

GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BIOPSY; CHILD; COMPLEMENT C3; DISEASE PROGRESSION; FEMALE; HUMANS; IRELAND; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; LONDON; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84891885176     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04700513     Document Type: Article

References (20)

1. Walport MJ: Complement. First of two parts. N Engl J Med 344: 1058-1066, 2001
2. Rodríguez de Córdoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sánchez-Corral P: The human complement factor H: Functional roles, genetic variations and disease associations. Mol Immunol 41: 355-367, 2004
3. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA: Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421, 2005
4. Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF: Membranoproliferative glomerulonephritis type II (dense deposit disease): An update. J Am Soc Nephrol 16: 1392-1403, 2005
5. Fakhouri F, Frémeaux-Bacchi V, Noël LH, Cook HT, Pickering MC: C3 glomerulopathy: A new classification. Nat Rev Nephrol 6: 494-499, 2010
6. Barbour TD, Pickering MC, Cook HT: Recent insights into C3 glomerulopathy. Nephrol Dial Transplant 28: 1685-1693, 2013
7. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC: Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376: 794-801, 2010
8. Malik TH, Lavin PJ, Goicoechea de Jorge E, Vernon KA, Rose KL, Patel MP, de Leeuw M, Neary JJ, Conlon PJ, Winn MP, Pickering MC: A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J Am Soc Nephrol 23: 1155-1160, 2012
9. Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V: Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82: 454-464, 2012
10. Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ: C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int 82: 465-473, 2012
11. Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, Markowitz GS, D'Agati VD: Dense deposit disease: Clinicopathologic study of 32 pediatric and adult patients. Clin J AmSoc Nephrol 4: 22-32, 2009
12. Athanasiou Y, Voskarides K, Gale DP, Damianou L, Patsias C, Zavros M, Maxwell PH, Cook HT, Demosthenous P, Hadjisavvas A, Kyriacou K, Zouvani I, Pierides A, Deltas C: Familial C3 glomerulopathy associated with CFHR5 mutations: Clinical characteristics of 91 patients in 16 pedigrees. Clin J Am Soc Nephrol 6: 1436-1446, 2011
13. Vernon KA, Goicoechea de Jorge E, Hall AE, Fremeaux-Bacchi V, Aitman TJ, Cook HT, Hangartner R, Koziell A, Pickering MC: Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am J Kidney Dis 60: 121-125, 2012
14. Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ: Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83: 293-299, 2013
15. Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ: Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int 69: 504-511, 2006
16. Licht C, Weyersberg A, Heinen S, Stapenhorst L, Devenge J, Beck B, Waldherr R, Kirschfink M, Zipfel PF, Hoppe B; C L: Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15. Am J Kidney Dis 45: 415-421, 2005
17. Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB: Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7: 748-756, 2012
18. Daina E, Noris M, Remuzzi G: Eculizumab in a patient with dense-deposit disease. N Engl J Med 366: 1161-1163, 2012
19. McCaughan JA, O'Rourke DM, Courtney AE: Recurrent dense deposit disease after renal transplantation: An emerging role for complementary therapies. Am J Transplant 12: 1046-1051, 2012
20. Vivarelli M, Pasini A, Emma F: Eculizumab for the treatment of dense-deposit disease. N Engl J Med 366: 1163-1165, 2012